Plasma human immunodeficiency virus RNA below 40 copies/mL is rare in untreated persons even in the first years of infection

Journal of Infectious Diseases

Volumn 180, Issue 2, 1999, Pages 526-529

  Lefrère, Jean Jacques ^a,c   Mariotti, Martine ^a   Morand Joubert, Laurence ^a   Thauvin, Micheline ^a   Roudot Thoraval, Françoise ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD; VIREMIA;

EID: 0033511779     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314906     Document Type: Article

References (12)

1. 1. Van Gemen B, Van Beunningen R, Nabbe A, et al. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J Virol Methods 1994; 49:157-67.
2. 2. Pachl C, Todd JA, Kern DG, et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched-DNA (BDNA) signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:446-54.
3. 3. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma; application to acute retroviral infection. J Clin Microbiol 1994; 32:292-300.
4. 4. Mulder J, Resnick R, Saget B, et al. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity. J Clin Microbiol 1997; 35:1278-80.
5. 5. Ginocchio CC, Tetali S, Washburn D, Zhang F, Kaplan MH. Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSense nucleic acid sequence-bused amplification and Quantiplex branched-DNA assays. J Clin Microbiol 1999; 37:1210-2.
6. 6. Collins ML, Irvine B, Tyner D, et al. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/mL. Nucleic Acids Res 1997; 25:2979-82.
7. 7. Segondy M, Ly TD, Lapeyre M, Montes B. Evaluation of the Nuclisens GIV-1 QT ussay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol 1998; 36:3372-4.
8. 8. Learmont J, Tindall B, Evans L, et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992; 340:863-7.
9. 9. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995; 332:209-16.
10. 10. Lefrère JJ, Morand-Joubert L, Mariotti M, et al. Even individuals considered as "long-term nonprogressors" show biological signs of progression after ten years of human immunodeficiency virus (HIV) infection. Blood 1997; 90:1133-40.
11. 11. Lefrère JJ, Roudot-Thoraval F, Mariotti M, Thauvin M, Lerable J, Morand-Joubert L. The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection. J Infect Dis 1998; 177:1541-8.
12. 12. Raboud JM, Montaner JSG, Conway B, et al. Suppression of plasma viral load below 20 copies/mL is required to achieve a long-term response to therapy. AIDS 1998; 12:1619-24.